WO2005114221A3 - Compositions and methods for quantification of serum glycoproteins - Google Patents

Compositions and methods for quantification of serum glycoproteins Download PDF

Info

Publication number
WO2005114221A3
WO2005114221A3 PCT/US2005/017842 US2005017842W WO2005114221A3 WO 2005114221 A3 WO2005114221 A3 WO 2005114221A3 US 2005017842 W US2005017842 W US 2005017842W WO 2005114221 A3 WO2005114221 A3 WO 2005114221A3
Authority
WO
WIPO (PCT)
Prior art keywords
compositions
methods
quantification
serum glycoproteins
human serum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2005/017842
Other languages
French (fr)
Other versions
WO2005114221A8 (en
WO2005114221A2 (en
Inventor
Rudolf H Aebersold
Hui Zhang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institute for Systems Biology
Original Assignee
Institute for Systems Biology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institute for Systems Biology filed Critical Institute for Systems Biology
Priority to DE602005013670T priority Critical patent/DE602005013670D1/en
Priority to DK05751819T priority patent/DK1766412T3/en
Priority to EP05751819A priority patent/EP1766412B1/en
Publication of WO2005114221A2 publication Critical patent/WO2005114221A2/en
Publication of WO2005114221A8 publication Critical patent/WO2005114221A8/en
Anticipated expiration legal-status Critical
Publication of WO2005114221A3 publication Critical patent/WO2005114221A3/en
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842—Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2400/00—Assays, e.g. immunoassays or enzyme assays, involving carbohydrates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2458/00—Labels used in chemical analysis of biological material
    • G01N2458/15—Non-radioactive isotope labels, e.g. for detection by mass spectrometry

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The invention provides compositions and methods for identifying and/or quantifying glycopolypeptides from human serum or plasma. The compositions and methods include a plurality of standard peptides containing glycosylation sites determined for human serum/plasma proteins.
PCT/US2005/017842 2004-05-21 2005-05-20 Compositions and methods for quantification of serum glycoproteins Ceased WO2005114221A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
DE602005013670T DE602005013670D1 (en) 2004-05-21 2005-05-20 COMPOSITIONS AND METHOD FOR QUANTITATING SERUM GLYCOPROTEINS
DK05751819T DK1766412T3 (en) 2004-05-21 2005-05-20 Compositions and Methods for Quantifying Serum Glycoproteins
EP05751819A EP1766412B1 (en) 2004-05-21 2005-05-20 Compositions and methods for quantification of serum glycoproteins

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57359304P 2004-05-21 2004-05-21
US60/573,593 2004-05-21

Publications (3)

Publication Number Publication Date
WO2005114221A2 WO2005114221A2 (en) 2005-12-01
WO2005114221A8 WO2005114221A8 (en) 2006-05-04
WO2005114221A3 true WO2005114221A3 (en) 2006-12-21

Family

ID=35429005

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2005/017842 Ceased WO2005114221A2 (en) 2004-05-21 2005-05-20 Compositions and methods for quantification of serum glycoproteins

Country Status (6)

Country Link
US (2) US20060141528A1 (en)
EP (4) EP1766412B1 (en)
AT (1) ATE427499T1 (en)
DE (1) DE602005013670D1 (en)
DK (1) DK1766412T3 (en)
WO (1) WO2005114221A2 (en)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1311858B1 (en) * 2000-05-05 2006-11-02 Purdue Research Foundation Affinity selected signature peptides for protein identification and quantification
WO2003027682A2 (en) * 2001-09-27 2003-04-03 Purdue Research Foundation Controlling isotope effects during fractionation of analytes
DE10254601A1 (en) 2002-11-22 2004-06-03 Ganymed Pharmaceuticals Ag Gene products differentially expressed in tumors and their use
US7384754B2 (en) * 2003-10-31 2008-06-10 Agilent Technologies, Inc. Enrichment and tagging of glycosylated proteins
DE102004024617A1 (en) 2004-05-18 2005-12-29 Ganymed Pharmaceuticals Ag Differentially expressed in tumors gene products and their use
EP1938104A2 (en) * 2005-10-17 2008-07-02 Institute for Systems Biology Tissue-and serum-derived glycoproteins and methods of their use
EP1790664A1 (en) 2005-11-24 2007-05-30 Ganymed Pharmaceuticals AG Monoclonal antibodies against claudin-18 for treatment of cancer
AU2007284651B2 (en) 2006-08-09 2014-03-20 Institute For Systems Biology Organ-specific proteins and methods of their use
US7879799B2 (en) * 2006-08-10 2011-02-01 Institute For Systems Biology Methods for characterizing glycoproteins and generating antibodies for same
AU2007342674B2 (en) 2007-01-10 2013-09-19 Purdue Research Foundation Polypeptide inhibitors of HSP27 kinase and uses therefor
WO2008134526A2 (en) * 2007-04-27 2008-11-06 University Of Florida Research Foundation Inc. Glycoprotein profiling of bladder cancer
WO2008151238A1 (en) * 2007-06-04 2008-12-11 The Johns Hopkins University Biomarkers for prostate cancer
US20100168382A1 (en) * 2007-06-12 2010-07-01 Vladimir Berezin Neuroplastin derived peptides
JP2010530962A (en) 2007-06-12 2010-09-16 グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー Methods for detecting proteins in plasma
CA2692970A1 (en) * 2007-07-03 2009-01-08 Northeastern University Biomarkers for diabetes, obesity, and/or hypertension
EP2178551A4 (en) * 2007-07-24 2010-07-21 Sanare Invest As NEW PEPTIDES
JP5703466B2 (en) 2007-08-07 2015-04-22 パーデュー・リサーチ・ファウンデーションＰｕｒｄｕｅ Ｒｅｓｅａｒｃｈ Ｆｏｕｎｄａｔｉｏｎ Kinase inhibitors and uses thereof
AU2009208607B2 (en) * 2008-01-31 2013-08-01 Compugen Ltd. Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
CA2744104C (en) 2008-12-10 2017-07-18 Purdue Research Foundation Cell-permeant peptide-based inhibitor of kinases
WO2010129187A1 (en) * 2009-05-08 2010-11-11 Thermo Finnigan Llc Methods and systems for matching productions to precursor ions
CN102695716B (en) * 2009-07-14 2016-03-02 独立行政法人产业技术综合研究所 Liver disease index sugar chain marker
US9890195B2 (en) 2009-07-27 2018-02-13 Purdue Research Foundation MK2 inhibitor compositions and methods to enhance neurite outgrowth, neuroprotection, and nerve regeneration
US10497466B2 (en) 2010-05-14 2019-12-03 Dh Technologies Development Pte. Ltd. Systems and methods for calculating protein confidence values
EP2632479B1 (en) * 2010-10-27 2017-06-14 Baxalta GmbH Fviii peptides for immune tolerance induction and immunodiagnostics
WO2012075042A1 (en) 2010-11-29 2012-06-07 Integrated Diagnostics, Inc. Diagnostic lung cancer panel and methods for its use
US8772043B2 (en) 2010-12-23 2014-07-08 Pioneer Hi Bred International Inc Universal peptide tags for transgene polypeptide analysis by mass spectrometry
CA2835806A1 (en) * 2011-05-13 2012-11-22 King's College London Methods and compositions relating to platelet sensitivity
US8455624B2 (en) 2011-06-03 2013-06-04 University Of South Alabama Methods and compositions for detecting endometrial or ovarian cancer
US9506167B2 (en) 2011-07-29 2016-11-29 Ginkgo Bioworks, Inc. Methods and systems for cell state quantification
WO2013039477A1 (en) 2011-09-12 2013-03-21 University Of South Alabama Non-invasive methods of detecting target molecules
CN103134874B (en) * 2011-12-01 2015-05-20 成都康弘生物科技有限公司 Method of measuring glycosyl in protein
US11913957B2 (en) 2011-12-21 2024-02-27 Biodesix, Inc. Compositions, methods and kits for diagnosis of lung cancer
CA2860298A1 (en) 2011-12-21 2013-06-27 Biodesix, Inc. Compositions, methods and kits for diagnosis of lung cancer
US9304137B2 (en) 2011-12-21 2016-04-05 Integrated Diagnostics, Inc. Compositions, methods and kits for diagnosis of lung cancer
CA3077804C (en) 2012-01-09 2023-07-25 Serpin Pharma, Llc Peptides and methods of using same
WO2013134636A1 (en) 2012-03-09 2013-09-12 Purdue Research Foundation Compositions and methods for delivery of kinase inhibiting peptides
WO2013167153A1 (en) 2012-05-09 2013-11-14 Ganymed Pharmaceuticals Ag Antibodies useful in cancer diagnosis
EP2918600B1 (en) * 2012-11-06 2019-04-24 University of Miyazaki Novel peptide and use thereof
WO2014100717A2 (en) 2012-12-21 2014-06-26 Integrated Diagnostics, Inc. Compositions, methods and kits for diagnosis of lung cancer
EP2972375A2 (en) 2013-03-13 2016-01-20 Creatics LLC Methods and compositions for detecting pancreatic cancer
GB201310150D0 (en) * 2013-06-07 2013-07-24 Electrophoretics Ltd Methods and compositions relating to alzheimer's disease
US9297805B2 (en) 2013-07-26 2016-03-29 Integrated Diagnostics, Inc. Compositions, methods and kits for diagnosis of lung cancer
WO2015117133A1 (en) 2014-02-03 2015-08-06 Integrated Diagnostics, Inc. Integrated quantification method for protein measurements in clinical proteomics
GB201411037D0 (en) * 2014-06-20 2014-08-06 Immatics Biotechnologies Gmbh Novel immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemai (CLL)
HRP20200967T1 (en) 2014-06-20 2020-10-16 Immatics Biotechnologies Gmbh Novel immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemia (cll)
WO2016038608A1 (en) * 2014-09-08 2016-03-17 Carmel Haifa University Economic Corporation Ltd. Peptides derived from angiotensin receptor and use thereof
WO2016054114A1 (en) 2014-09-29 2016-04-07 The Regents Of The University Of California Compositions for expanding regulatory t cells (treg), and treating autoimmune and inflammatory diseases and conditions
GB201505305D0 (en) * 2015-03-27 2015-05-13 Immatics Biotechnologies Gmbh Novel Peptides and combination of peptides for use in immunotherapy against various tumors
LT3388075T (en) 2015-03-27 2023-11-10 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against various tumors (seq id 25 - mrax5-003)
WO2017040287A1 (en) 2015-08-28 2017-03-09 Serpin Pharma, Llc Methods for treatment of diseases
GB201520559D0 (en) * 2015-11-23 2016-01-06 Immunocore Ltd & Adaptimmune Ltd Peptides
GB201520550D0 (en) 2015-11-23 2016-01-06 Immunocore Ltd & Adaptimmune Ltd Peptides
GB201520568D0 (en) 2015-11-23 2016-01-06 Immunocore Ltd Peptides
CN110114680A (en) 2016-05-05 2019-08-09 佰欧迪塞克斯公司 For the composition of diagnosing, method and kit
US9960027B2 (en) 2016-05-25 2018-05-01 Thermo Finnigan Llc Analyzing a complex sample by MS/MS using isotopically-labeled standards
CN111148844A (en) * 2017-09-01 2020-05-12 韦恩生物科技股份公司 Identification and use of glycopeptides as biomarkers for diagnosis and therapeutic monitoring
ES2710321A1 (en) * 2017-10-20 2019-04-24 Consejo Superior Investigacion DNA INDEPENDENT POLYMERASES OF PRIMER AND THEIR USE FOR DNA SYNTHESIS (Machine-translation by Google Translate, not legally binding)
WO2020223646A1 (en) 2019-05-02 2020-11-05 Creatics Llc Methods for cancer detection by evaluation of alpha-1-antitrypsin (aat) and chymotrypsin-like elastase in gastrointestinal lavage fluid samples
CN110563844A (en) * 2019-09-04 2019-12-13 华中农业大学 A kind of polyclonal antibody against canine interleukin 31 receptor and its application
WO2021050510A1 (en) * 2019-09-09 2021-03-18 The Wistar Institute Of Anatomy And Biology Engineered peptide and peptide mimetic compositions and methods
EP4143564B1 (en) * 2020-04-28 2024-06-05 Janssen Pharmaceuticals, Inc. Method for identification and quantification of polysaccharides in complex glycoconjugate compositions
US12105093B2 (en) 2020-07-28 2024-10-01 University Of Washington Quantitation of GLA proteins by mass spectrometric analysis
EP4053559A1 (en) * 2021-03-01 2022-09-07 Consorcio Centro de Investigación Biomédica en Red, M.P. (CIBER) Methods for the measurement of protein c and activated protein c
EP4329793A4 (en) * 2021-04-29 2025-03-05 Seer, Inc. Peptide decorated nanoparticles for enrichment of specific protein subsets
CN113480629B (en) * 2021-06-16 2022-08-19 复旦大学 Terminal sialylated isomeric glycopeptide marker for distinguishing liver cancer from normal person and screening method thereof
CN115490763A (en) * 2021-06-18 2022-12-20 佛山热休生物技术有限公司 Epitope peptide of LUM and complex of said epitope peptide and heat shock protein
US11542340B1 (en) 2021-10-29 2023-01-03 Biodesix, Inc. Antibodies targeting pulmonary nodule specific biomarkers and uses thereof
NL2030990B1 (en) * 2022-02-17 2023-09-01 Academisch Ziekenhuis Leiden T cell receptors directed against jchain and uses thereof
WO2023164697A2 (en) * 2022-02-28 2023-08-31 PrognomIQ, Inc. Glycoprotein assessment
US20240228671A1 (en) * 2022-10-21 2024-07-11 Quantum-Si Incorporated Polypeptidyl linkers
CN117969642B (en) * 2024-04-02 2024-07-23 浙江大学 An accurate relative quantitative analysis method for plant N-glycans and its application

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000073801A2 (en) * 1999-05-28 2000-12-07 Ludwig Institute For Cancer Research Breast, gastric and prostate cancer associated antigens and uses therefor
WO2003102018A2 (en) * 2002-06-03 2003-12-11 The Institute For Systems Biology Methods for quantitative proteome analysis of glycoproteins

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2226032B (en) * 1988-12-16 1993-08-18 Urs Heimgartner Detection of glycoproteins
US5744101A (en) 1989-06-07 1998-04-28 Affymax Technologies N.V. Photolabile nucleoside protecting groups
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5079336A (en) * 1989-06-23 1992-01-07 The Trustees Of The University Of Pennsylvania α-1-antichymotrypsin, analogues and methods of production
US5264563A (en) 1990-08-24 1993-11-23 Ixsys Inc. Process for synthesizing oligonucleotides with random codons
GB9112504D0 (en) * 1991-06-11 1991-07-31 Merck Sharp & Dohme Cell line
US5986076A (en) 1994-05-11 1999-11-16 Trustees Of Boston University Photocleavable agents and conjugates for the detection and isolation of biomolecules
EP0776330B1 (en) 1994-06-23 2003-08-20 Affymax Technologies N.V. Photolabile compounds and methods for their use
CA2257357C (en) * 1996-06-07 2010-04-13 Neorx Corporation Humanized antibodies with modified glycosylation
US6328969B1 (en) * 1996-12-10 2001-12-11 Sloan-Kettering Institute For Cancer Research Method and compositions for stimulation of an immune response to a differentiation antigen stimulated by an altered differentiation antigen
US6046013A (en) * 1997-08-01 2000-04-04 Gti Process for identifying specific antibodies associated with HLA
US6670194B1 (en) 1998-08-25 2003-12-30 University Of Washington Rapid quantitative analysis of proteins or protein function in complex mixtures
US6407210B1 (en) * 1998-11-09 2002-06-18 University Of Utah Research Foundation Nematode neuromuscular junction GABA receptors and methods related thereto
EP1739424B1 (en) 2000-12-26 2011-08-24 The Institute for Systems Biology Rapid and quantitative proteome anaysis and related methods
CA2444882A1 (en) * 2001-04-30 2002-11-07 Vertex Pharmaceuticals Incorporated Inhibitors of gsk-3 and crystal structures of gsk-3.beta. protein and protein complexes
WO2003027682A2 (en) * 2001-09-27 2003-04-03 Purdue Research Foundation Controlling isotope effects during fractionation of analytes
WO2005007677A2 (en) * 2003-07-10 2005-01-27 The Institute For Systems Biology Affinity capture of peptides by microarray and related methods
US7593336B2 (en) * 2003-10-31 2009-09-22 Brocade Communications Systems, Inc. Logical ports in trunking
US7348416B2 (en) * 2003-11-21 2008-03-25 Applera Corporation Selective capture and enrichment of proteins expressed on the cell surface

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000073801A2 (en) * 1999-05-28 2000-12-07 Ludwig Institute For Cancer Research Breast, gastric and prostate cancer associated antigens and uses therefor
WO2003102018A2 (en) * 2002-06-03 2003-12-11 The Institute For Systems Biology Methods for quantitative proteome analysis of glycoproteins

Also Published As

Publication number Publication date
ATE427499T1 (en) 2009-04-15
US20060141528A1 (en) 2006-06-29
WO2005114221A8 (en) 2006-05-04
US20100279382A1 (en) 2010-11-04
EP1766412B1 (en) 2009-04-01
EP2302394A1 (en) 2011-03-30
EP1766412A2 (en) 2007-03-28
EP2302393A8 (en) 2011-08-03
WO2005114221A2 (en) 2005-12-01
DE602005013670D1 (en) 2009-05-14
EP2302393A1 (en) 2011-03-30
DK1766412T3 (en) 2009-05-25
EP2093569A2 (en) 2009-08-26
EP2093569A3 (en) 2009-11-11

Similar Documents

Publication Publication Date Title
WO2005114221A8 (en) Compositions and methods for quantification of serum glycoproteins
WO2004070351A3 (en) Protein fragment complementation assays for high-throughput and high-content screening
IL200608A0 (en) Methods for the detection of 193p1e1b protein and use of compositions containing a 193p1e1b protein or an antibody binding thereto
IL210619A0 (en) Compositions and processes for analyte detection
PL373962A1 (en) Methods and compositions for analyzing proteins
AU2002317618A1 (en) System and method for automated analysis of load testing results
WO2003016527A3 (en) Process for the detection of oxidative stress and kit for its implementation
WO2005012574A3 (en) Biological bar-code
AU2002338428A1 (en) Methods and systems for identifying proteins
AU2003237282A1 (en) Automated protein analysis system comprising capillary electrophoresis-tandem mass spectrometry
AU2002324902A1 (en) Serine/threonine hydrolase proteins and screening assays
AU2002349311A1 (en) Test strips for the detection of prion proteins
AU2003259707A1 (en) Mass spectrometry-based identification of proteins
WO2007095378A3 (en) Mass tagging for quantitative analysis of biomolecules using 13c labeled phenylisocyanate
EP1404707A4 (en) Systems and methods for the analysis of proteins
WO2002094777A3 (en) Methods of detecting protein arginine methyltransferase, and uses related thereto
AU2002365084A1 (en) Method and reagent for the detection of proteins and peptides
AU2003209735A1 (en) Filament-recruiting fluorescent proteins for the analysis and identification of protein-protein-interactions
AU2002237835A1 (en) Methods of analyzing and sorting one or more analytes
AU2001255582A1 (en) Reusable microarrays for quantifying low abundance proteins
WO2004070345A3 (en) Age determination on death
AU2003265865A1 (en) Methods of screening cyclic peptides and identifying targets therefor
AU2002321395A1 (en) Method for separating and/or detecting and/or identifying and/or quantifying prion proteins
WO2005015154A3 (en) Autocatalysis/yeast two-hybrid assay
AU2003298224A1 (en) Elisa method for the detection of guanylate binding protein 1 (gbp-1)

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: IN PCT GAZETTE 48/2005 UNDER (72, 75) REPLACE "AEBERSOLD, RUDOLPH, H." BY "ABERSOLD, RUDOLF, H."

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

WWE Wipo information: entry into national phase

Ref document number: 2005751819

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 2005751819

Country of ref document: EP